Candriam Equities L Oncology Impact C/ LU1864484214 /
NAV2024-05-30 | Chg.+0.0900 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
238.4900EUR | +0.04% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV2024-05-30 | Chg.+0.0900 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
238.4900EUR | +0.04% | reinvestment | Equity Worldwide | Candriam ▶ |